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AbstrAct
ObjeCtive
To evaluate the clinical efficacy of an established 
programme of occupational therapy in maintaining 
functional activity and reducing further health risks 
from inactivity in care home residents living with 
stroke sequelae.
Design
Pragmatic, parallel group, cluster randomised 
controlled trial.
setting
228 care homes (> 10 beds each), both with and 
without the provision of nursing care, local to 11 trial 
administrative centres across the United Kingdom.
PartiCiPants
1042 care home residents with a history of stroke or 
transient ischaemic attack, including those with 
language and cognitive impairments, not receiving end 
of life care. 114 homes (n = 568 residents, 64% from 
homes providing nursing care) were allocated to the 
intervention arm and 114 homes (n = 474 residents, 
65% from homes providing nursing care) to standard 
care (control arm). Participating care homes were 
randomised between May 2010 and March 2012.
interventiOn
Targeted three month programme of occupational 
therapy, delivered by qualified occupational therapists 
and assistants, involving patient centred goal setting, 
education of care home staff, and adaptations to the 
environment.
Main OutCOMe Measures
Primary outcome at the participant level: scores on the 
Barthel index of activities of daily living at three 
months post-randomisation. Secondary outcome 
measures at the participant level: Barthel index scores 
at six and 12 months post-randomisation, and scores 
on the Rivermead mobility index, geriatric depression 
scale-15, and EuroQol EQ-5D-3L questionnaire, at all 
time points.
results
64% of the participants were women and 93% were 
white, with a mean age of 82.9 years. Baseline 
characteristics were similar between groups for all 
measures, personal characteristics, and diagnostic 
tests. Overall, 2538 occupational therapy visits were 
made to 498 participants in the intervention arm 
(mean 5.1 visits per participant). No adverse events 
attributable to the intervention were recorded. 162 
(11%) died before the primary outcome time point, and 
313 (30%) died over the 12 months of the trial. The 
primary outcome measure did not differ significantly 
between the treatment arms. The adjusted mean 
difference in Barthel index score at three months was 
0.19 points higher in the intervention arm (95% 
confidence interval −0.33 to 0.70, P = 0.48). 
Secondary outcome measures also showed no 
significant differences at all time points.
COnClusiOns
This large phase III study provided no evidence of 
benefit for the provision of a routine occupational 
therapy service, including staff training, for care home 
residents living with stroke related disabilities. The 
established three month individualised course of 
occupational therapy targeting stroke related 
disabilities did not have an impact on measures of 
functional activity, mobility, mood, or health related 
quality of life, at all observational time points. 
Providing and targeting ameliorative care in this 
clinically complex population requires alternative 
strategies.
trial registratiOn
Current Controlled Trials ISRCTN00757750.
Introduction
Care homes are residential settings with staff employed 
to assist with personal care for people who unable to look 
after themselves. In the United Kingdom, care homes 
exist with and without the provision of nursing  care. 
WhAt Is AlreAdy knoWn on thIs topIc
Survivors of stroke residing in care homes tend to have increased cognitive and 
physical impairments than those living in the community
Occupational therapy provided to survivors of stroke living at home has good 
evidence of benefit
Evidence in the literature on the efficacy of occupational therapy for older residents 
of care homes is conflicting, but until now the randomised controlled trials have 
been small and underpowered
WhAt thIs study Adds
The results of this large phase III cluster randomised controlled trial found no 
evidence of benefit of a three month course of individualised occupational therapy, 
involving patient centred goal setting, education of staff, and adaptations to the 
environment for care home residents with stroke related disabilities
Observed limitations on functional activity in this population were more severe 
than anticipated
Providing and targeting ameliorative care in this clinically complex population 
requires alternative strategies
 open access
RESEARCH
2 the bmj | BMJ 2015;350:h246 | doi: 10.1136/bmj.h468
For homes providing nursing care, staff must be quali-
fied health professionals. Studying the evidence for effi-
cacious rehabilitation practices in long term 
institutional care settings is a research priority.1 Recent 
estimated global figures suggest that despite a decrease 
in incidence and prevalence of stroke mortality between 
1990 and 2010, stroke represents the third most com-
mon cause of disability adjusted life years.2 Within the 
United Kingdom, approximately a quarter of all survi-
vors of stroke are unable to return home and require 
long term institutional care.3
Care home residents with stroke related disabilities 
tend to be more physically and cognitively impaired 
than those living in the community, and consequently 
have high support needs. A primary objective of this 
trial was to evaluate the potential benefit of a course of 
occupational therapy at maintaining or improving 
functional activity in this population. The focus on 
functional activity reflects how health and disability are 
understood in the redrafted international classification 
of functioning, disability, and health in 2001.4 Disability 
is discussed in terms of the interaction between an indi-
vidual’s impairments, limitations of activity, restric-
tions to participation, and environment.4
After admission to a care home, residents with stroke 
related disabilities typically follow a downward trajec-
tory in their capacity to engage in functional activity. 
Observational data suggest that 97% of residents’ days 
are spent sitting and being inactive.5 Inactivity in this 
population poses further health risks, including joint 
contractures, pain, incontinence, pressure ulcers, and 
low mood.6 Occupational therapy delivered to stroke 
survivors in their own homes has strong evidence of 
benefit.7 8 Within its most recent stroke guidelines the 
UK National Institute for Health and Care Excellence 
recommends that occupational therapy should be pro-
vided for people after stroke who are likely to benefit, to 
tackle difficulties with personal activities of daily liv-
ing.9 This form of rehabilitative therapy is rarely avail-
able in UK care homes,10 and yet it is arguably more 
relevant and applicable to a care home setting, where 
residents’ have higher levels of dependence performing 
personal activities of daily living than those living in the 
community. Personal activities of daily living are 
defined as feeding, bathing, using the toilet, getting 
dressed, grooming, transfers (for example, from bed to 
chair and back), and mobility. Owing to the established 
literature base indicating efficacy of occupational ther-
apy for stroke survivors living within the community,7 8 
we deemed it necessary to focus this trial on residents 
in care homes with stroke sequelae. An objective of the 
trial was to evaluate whether there is evidence to recom-
mend an improved UK National Health Service provi-
sion of this type of therapy for care home residents with 
stroke related disabilities.
The research team has published a systematic review 
with the Cochrane Collaboration identifying ran-
domised controlled trials that examined the impact of 
an occupational therapy intervention, provided by 
trained therapists, for care home residents with stroke 
related disabilities, compared with usual care.11 
One study was analysed in full.12 This was the phase II 
cluster randomised controlled trial completed by mem-
bers of the research team. Overall, 118 participants were 
recruited from 12 care homes in one region of the United 
Kingdom. The intervention was similar in style and con-
tent to the trial reported here. The primary outcome 
measure was scores on the Barthel index,13 14 and the 
secondary outcome measures were scores on the River-
mead mobility index15 and poor global outcome. Poor 
global outcome was defined as deterioration in Barthel 
index score or death. Measures were conducted at three 
and six months after randomisation. Residents receiv-
ing the intervention showed a moderate improvement 
in Barthel index and Rivermead mobility index scores 
between baseline and the primary endpoint at three 
months. At the six month follow-up, participants’ level 
of deterioration was similar between the groups. The 
proportion of participants with a poor global outcome 
tended to be higher in the control arm at the three and 
six month endpoints. The pilot trial showed feasibility 
and suggested that a course of individualised occupa-
tional therapy may provide benefit in maintaining or 
increasing functional activity for residents in care 
homes with stroke related disabilities.12 However, 
owing to the small sample size and high intracluster 
correlations among the data, no firm conclusions could 
be drawn.11
We developed pilot findings using a larger sample of 
care home residents living with stroke related disabili-
ties and to evaluate whether a three month course of 
occupational therapy would have a significant clinical 
impact on functional activity compared with usual care. 
The results aimed to offer a robust assessment of 
whether occupational therapy should be recommended 
as part of a routine package to all care home residents 
living with stroke related disabilities.
Methods
study design and participants
This study was a phase III pragmatic, parallel group, 
cluster randomised controlled trial in care homes 
across the United Kingdom. We chose a cluster design 
because of the staff education and environmental adap-
tation components included in the intervention. The 
trial protocol is summarised here and described in full 
elsewhere.16 We invited a random selection of care 
homes with more than 10 beds each to participate in the 
study, in the geographical vicinity to a trial administra-
tive centre. The trial administrative centres were situ-
ated in the south, south west, Midlands, and north west 
of England, and in Wales. We included all funding mod-
els of care home; excluding homes for people with 
learning disabilities or drug addiction. Care home man-
agers were offered a full explanation of the study. No 
care homes were actively delivering occupational ther-
apy as a component of standard care.
Once the managers had given informed consent, care 
home staff searched the residents’ notes to determine 
confirmed or suspected stroke or transient ischaemic 
attack. Where a relevant entry was found, the research 
team sought confirmation from general practice 
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records. Where stroke was suspected, residents were 
described as having experienced a stroke in care home 
records; however, these details were not confirmed by a 
doctor, following multiple attempts. All residents with 
a history of ischaemic or haemorrhagic stroke or tran-
sient ischaemic attack, including those with language 
and cognitive impairments, were eligible. We excluded 
residents actively receiving end of life care. Residents 
with a history of transient ischaemic attack were 
included owing to the emerging evidence that long term 
moderate to severe difficulties are experienced in 26% 
of cases.17 We offered prospective participants (and fam-
ily members, if appropriate) a full explanation of the 
study. If prospective participants lacked the capacity to 
consent, we approached their next of kin to provide 
consultee agreement on their behalf.18 During a second 
visit to the care home, trained assessors or care home 
staff obtained consent from eligible residents.
randomisation and masking
To reduce bias, independent assessors administered 
baseline assessments before randomisation.19 No addi-
tional participants joined the study after randomisa-
tion. If a care home had at least one consenting 
resident, it was eligible for randomisation. We stratified 
care homes by type of care provided (nursing or resi-
dential) and trial administrative centre (11 centres), and 
then randomised them 1:1 to either the intervention arm 
or the control arm. An independent statistician gener-
ated an allocation sequence in nQuery Advisor, version 
7.0 (Statistical Solutions, Cork, Republic of Ireland) 
using randomised blocks (size = 2) within strata. To 
reduce predictability we randomised homes in batches 
across the strata. The sequence was concealed from the 
research team and held in a secure database. Homes 
were randomised once the study coordinator logged the 
details about the stratification factors and received noti-
fication that all consenting participants in a care 
home had completed baseline measures. Care home 
allocation was revealed to the study coordinator, who 
then informed the care home manager and corre-
sponding site therapist. The study coordinator was 
not involved in data collection or data analysis. Inde-
pendent assessors were masked to the treatment allo-
cation of care homes.
intervention and control
Residents in the control arm received usual care. This 
did not involve an occupational therapy component. 
The occupational therapy intervention at the level of 
the care home resident followed a client centred 
approach, involving task specific training delivered by 
qualified occupational therapists (box).20
The intervention package was developed using evi-
dence and expert consensus opinion from occupa-
tional therapists, trialled previously in a stroke 
population,12 and described in detail in previous publi-
cations.21 22 The intervention was customised to each 
resident and aimed to augment or maintain functional 
capacity in personal activities of daily living, such as 
dressing, grooming, bathing, using the toilet, feeding, 
and mobility. Therapists made appropriate environ-
mental adaptations where necessary, to promote safe 
and effective practice of personal activities of daily liv-
ing (for example, the installation of bed levers, grab 
rails, raised toilet seats). Environmental adaptations 
were made according to each therapist’s professional 
opinion.
Occupational therapists assessed residents in the 
intervention group to establish baseline functional abil-
ity and identify areas of activity limitation that could be 
dealt with during treatment. Task performance goals for 
the intervention were mutually agreed between the 
therapist and resident. For residents with communica-
tion or cognitive difficulties the therapist included fam-
ily members or care home staff to agree the shared goals 
of therapy. The frequency and duration of therapy ses-
sions depended on the resident’s wishes and the agreed 
goals of therapy.
We provided specific training workshops as part of 
the intervention package to staff in homes randomised 
to the intervention group.21 The workshops aimed to 
increase awareness of stroke related disabilities and 
provide advice on their management in relation to long 
term care. Risks associated with inactivity were high-
lighted, as well as the carer’s role in supporting mobil-
ity (for example, safe and effective methods of transfer), 
preventing accumulative problems from poor position-
ing (for example, unsuitable seating), and facilitating 
resident participation in self care activities.5 For staff in 
care homes randomised to the control arm, we offered a 
training workshop after the 12 month follow-up. The 
training offered to care home staff received endorse-
ment from the UK Stroke Forum Education and Training 
(www.stroke-education.org.uk/).
suMMAry of occupAtIonAl therApy InterventIon
•	 Therapy followed a patient centred goal setting approach, aiming to improve or 
maintain functional capacity in personal activities of daily living
•	 Therapy was administered according to categories:
 Assessment and goal setting—involving the assessment of a resident’s cur-
rent level of functional activity in personal activities of daily living and 
mutually identifying functional goals of therapy
 Personal activities of daily living training—involving techniques to assist 
with feeding, bathing, using the toilet, getting dressed, and grooming
 Transfers and mobility—involving walking, standing, moving around in 
bed, and transfers to and from a chair
 Communication—involving the provision of information and guidance 
(to staff, residents, or relatives), referrals to other agencies, ordering equip-
ment, and listening to residents’ concerns about personal activities of daily 
living
 Environment (including adaptive equipment and seating posture)—involving 
provision of items such as adaptive cutlery, palm protectors, wheelchair 
cushions, walking aids, chair raisers, grab rails, raised toilet seats, and bed 
levers
 Other—involving treating impairments directly, such as joint contracture
•	 Frequency and duration of visits depended on agreed goals between therapist 
and resident
•	 Workshops for care home staff focused on facilitating residents’ functional 
 activity, mobility, and use of adaptive equipment
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Outcome measures
The primary outcome measure was the Barthel index 
score at the participant level, three months post-rando-
misation.13 14 We conducted secondary follow-up assess-
ments of the Barthel index score at six and 12 months 
post-randomisation. The Barthel index consists of a 
scale between 0 and 20, 20 signifying maximum abil-
ity.13 22 It assesses levels of dependency in 10 categories 
of self care (for example, dressing, feeding). An increase 
of 2 points is accepted as being clinically significant.23 
A 2 point change equates to a perceptible step change in 
function. For example, in the self care dimensions an 
increase of 2 points may indicate a change from being 
unable to dress and feed oneself to managing with 
some form of help. Care home staff assisted residents 
who were unable to complete the Barthel index. At 
baseline the Sheffield screening test for acquired lan-
guage disorders was administered along with the 
mini-mental state examination.24 25 The tests provided 
an indication of the participant’s capacity to under-
stand instructions and directly engage in therapy, and 
informed the research team whether they required con-
sultee assistance during recruitment.
Secondary outcome measures included the River-
mead mobility index,15 geriatric depression scale-15,26 
and EuroQol EQ-5D-3L questionnaire.27 All secondary 
outcome measures were assessed at all follow-up time 
points. Independent assessors, blinded to treatment 
allocation, were trained in conducting all outcome 
measures and completed all assessments in their allo-
cated homes. Recorded personal data included age, 
sex, ethnicity, comorbidities, and history of falls before 
the onset of the trial. Adverse events were defined as a 
fall that led to a consultation with a general practi-
tioner or visit to an emergency department as a result 
of participating in the study, including cases of adap-
tive equipment failure (for example, breakage of a 
walking aid).
statistical analyses
To observe a clinically significant 2 point increase in 
mean Barthel index score at three months,23 we esti-
mated that we would require a sample size of 330 resi-
dents in each treatment arm. This estimate was based 
on a standard deviation of 3.7, with 90% power at the 
5% significance level, and an intracluster correlation 
coefficient of 0.37.28 The sample size calculation was 
estimated from data related to several pilot stud-
ies.12 28 29 We used the larger estimate to calculate sam-
ple size in the interest of adequate power. Assuming an 
attrition rate of 26%12 and a total of 10 residents per 
home, we estimated that 45 care homes would be 
required in each treatment arm (n = 900 residents).
Analyses were performed in Stata (version 12.1) and 
SAS (version 9.2) software using mixed and glimmix 
procedures. All analyses were performed using an 
intention to treat approach, whereby participants were 
analysed by the arm to which their initial home of resi-
dence was randomised. The primary linear mixed 
model analysis compared Barthel index scores between 
groups at three months. We adjusted the analysis by 
care home (as a random factor), baseline Barthel index 
score, and stratification factors: trial administrative 
centre (11 centres) and type of care home (residential or 
nursing). Participants who died before a follow-up 
assessment were assigned a Barthel index score of zero 
for all subsequent follow-up assessments. In the pri-
mary analysis we excluded participants with missing or 
incomplete data for Barthel index scores.
In addition, participants were categorised into three 
outcome groups based on their change in Barthel index 
score at three months from baseline (< 0 or death = poor, 
0–1 = moderate, ≥ 2 = good). We used a non-linear 
mixed effects model to compare this ordinal outcome 
between the groups. Sensitivity analyses excluded clus-
ters with fewer than three participants and examined 
the effects of missing data using best case (last value 
carried forward), worst case (zero), and multiple impu-
tation methods. Participants who died were imputed 
with a zero score for all sensitivity analyses. We per-
formed further secondary analyses on the Barthel index 
data to assess the effects of the three month interven-
tion over time. A repeated measures mixed model anal-
ysis of Barthel index scores was performed across all 
endpoints, adjusted using an identical method to the 
primary analysis. We also performed secondary 
between group analyses on the Rivermead mobility 
index, geriatric depression scale-15, and EQ-5D-3L data 
at all endpoints. In addition to the evaluation of clinical 
efficacy we also performed an economic analysis that 
assessed the cost of the intervention per quality 
adjusted life year.
results
Participants
Figure 1 shows the flow of participants through the 
study. A total of 237 care homes offered consent at a 
managerial level across the 12 administrative centres. 
Within the consenting care homes 1556 out of 9840 
(16%) residents were eligible for the study; 1055 of the 
1556 (68%) provided consent to participate. One trial 
administrative centre, involving four care homes and 
11 consenting residents withdrew before the randomi-
sation stage owing to problems during the start-up 
phase. Eleven trial administrative centres were 
involved in the remainder of trial. Four care homes 
with consent at a managerial level across two admin-
istrative centres did not recruit any consenting partic-
ipants and were withdrawn. Two consenting 
participants in a single care home were withdrawn by 
the care home manager before randomisation to 
receive end of life care. As a result the care home was 
withdrawn. A total of nine care homes, involving 13 
consenting participants, did not proceed to the rando-
misation stage (fig 1).
The trial was planned for four years but the antici-
pated end date was brought forward from December 
2014 to February 2013 owing to high recruitment levels. 
Randomisation of participating care homes occurred 
between May 2010 and March 2012. Recruitment 
exceeded the target, with 1042 participants from 228 
care homes (114 homes in each arm) local to 11 trial 
RESEARCH
5the bmj | BMJ 2015;350:h246 | doi: 10.1136/bmj.h468
administrative centres across England and Wales. We 
recruited more care homes because the average cluster 
size was lower than predicted but comparable between 
the two arms (Table 1). The median size of clusters was 
4 (interquartile range 2–6). Of the care homes recruited, 
121 (53%) provided nursing care. Most participants 
resided in homes with nursing care (64%). More eligi-
ble residents resided in clusters randomised to the 
intervention arm (n = 568) than the control arm 
(n = 474). This was a chance occurrence as consent was 
obtained before randomisation. Overall, 64% of the 
participants were female, and the mean age was 82.9 
(SD 9.2) years.
baseline characteristics
Baseline characteristics for all personal characteristics 
and diagnostic tests were similar between the treatment 
groups (Table 1). Data on length of stay in the care home 
were available for 562/568 (99%) participants in the 
intervention arm and 467/474 (99%) participants in the 
control arm. The median length of stay between care 
home admission and trial randomisation was 2.35 
(interquartile range 0.96–4.49) years for the interven-
tion group and 2.16 (1.04–4.12) years for the control 
group. We attempted to retrieve the exact dates of par-
ticipants’ stroke from medical records, but responses 
from general practices were limited to approximately 
46% of all participants. Date of stroke was confirmed 
for 225 participants in the intervention arm and 250 par-
ticipants in the control arm. The median duration 
between residents’ stroke and trial randomisation was 
3.17 (1.30–7.12) years in the intervention arm and 2.82 
(1.18–5.83) years in the control arm.
Most participants (542/760, 71%) who completed the 
mini-mental state examination scored between 0 and 
20 out of 30, indicating significant cognitive impair-
ment.24 30 For the Sheffield screening test, 458/798 
(57%) scored below 15, indicating impairment of com-
munication.25 In addition, 404/913 (44%) participants 
scored in the range signifying moderate depression on 
the geriatric depression scale-15 at baseline, and 
220/913 (24%) scored in the range indicative of severe 
depression (Table 1).26
Baseline data on the Barthel index for the primary 
analysis were recorded for 562/568 (99%) residents in 
the intervention group and 467/474 (99%) in the control 
group (Table 1). Over 70% of all participants were cate-
gorised as severe or very severe using the Barthel index. 
For the secondary analyses, baseline assessments were 
administered with a high completion rate for the River-
mead mobility index (97%), geriatric depression scale-
15 (88%), and EQ-5D-3L (89%) and were comparable 
between groups (Table 1). Fig 2 displays a plot of the 
relation between baseline Barthel index scores and 
baseline Rivermead mobility index scores for 1012 par-
ticipants across both treatment arms. A total of 493/1012 
(49%) participants scored less than 4 on both the River-
mead mobility index and Barthel index scales, suggest-
ing that approximately half of the sampled population 
had both severe limitations on functional activity when 
engaging in personal activities of daily living, and 
severe limitations with mobility.
intervention
Overall, 2538 visits were made to 498 residents in the 
intervention arm: mean 5.1 (SD 3.0) visits. Total therapy 
time was 1724 hours. The median session duration was 
30 (interquartile range 15–60) minutes. Therapy was 
administered according to categories: 23% of therapy 
time was spent on individual assessment, 49% on com-
munication, 7% on activities of daily living training, 8% 
on mobility training, 7% on the provision of adaptive 
equipment, and 6% on treating specific impairments. 
Time spent on communication involved the provision of 
information and guidance for staff, residents, or rela-
tives; referrals to other agencies; and ordering relevant 
equipment. Table 2 shows examples of treatment plans 
for personal activities of daily living and mobility train-
ing or the use of adaptive equipment in three hypothet-
ical residents.
 Allocated to control
group in 114 homes (n=474)
 Allocated to occupational therapy
group in 114 homes (n=568)
Received allocation (n=458)Received allocation (n=545)
Eligible from 237 homes (n=1556)
Included from 228 homes with consent before randomisation (n=1042 )
Excluded (n=514):
  Refused (n=501)
  Withdrawals from 9 homes (n=13)
Did not receive allocation (n=23): 
  Died (n=16)
  Withdrawals (1 died <3m) (n=7)
Excluded (n=54): 
  Died (n=47)
  Withdrawals (n=5)
  Lost to follow-up (n=2)
At 3 month assessment (n=491): 
  Completed primary outcome from 113 care
    homes (n=479)
  Incomplete (n=9)
  Missing (n=3)
At 3 month assessment (n=417): 
  Completed primary outcome from 111 care
    homes (n=391)
  Incomplete (n=12)
  Missing (n=14)
At 6 month assessment (n=445): 
  Completed primary outcome from 111 care
    homes (n=424)
  Incomplete (n=7)
  Missing (n=14)
At 6 month assessment (n=379): 
  Completed primary outcome from 109 care
    homes (n=369)
  Incomplete (n=2)
  Missing (n=8)
At 12 month assessment (n=384): 
  Completed primary outcome from 104 care
    homes (n=355)
  Incomplete (n=14)
  Missing (n=15)
At 12 month assessment (n=303): 
  Completed primary outcome from 100 care
    homes (n=285)
  Incomplete (n=7)
  Missing (n=11)
Excluded (n=41): 
  Died (n=36)
  Withdrawals (n=2)
  Lost to follow-up (n=3)
Excluded (n=38): 
  Died (n=34)
  Withdrawals (n=3)
  Lost to follow-up (n=1)
Excluded (n=76): 
  Died (n=66)
  Withdrawals (n=5)
  Lost to follow-up (n=5)
Excluded (n=61): 
  Died (n=55)
  Withdrawals (n=3)
  Lost to follow-up (n=3)
Did not receive allocation (n=16): 
  Died (n=15)
  Withdrawals (1 died <3m) (n=1)
Excluded (n=46): 
  Died (n=42)
  Withdrawals (n=4)
Fig 1 | Flow of participants through study
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attrition and cases of unblinding
Retention of care home participation was good through-
out the study (fig 1). Completion rates for all primary 
and secondary measures were balanced between the 
two groups at each of the follow-up assessments. Pri-
mary outcome data were recorded in 224/228 (98%) care 
homes at the three month follow-up. Outcome mea-
sures were completed in 220/228 (96%) care homes at 
six months and 204/228 (89%) care homes at 12 months. 
The reason for withdrawal for 15/24 (63%) care homes 
was because all participating residents had died during 
follow-up. This occurred in 7/10 homes in the interven-
tion arm and 8/14 homes in the control arm over the 12 
month duration of the trial. Of the remaining withdraw-
als, the care home manager withdrew consent, with the 
exception of one care home in the intervention arm that 
was withdrawn before the primary endpoint owing to 
the treatment allocation being revealed to the assessor. 
In addition to this case of unblinding, five further cases 
occurred; one after the final 12 month assessment and 
the remainder after the primary outcome time point. All 
cases of unblinding occurred in homes allocated to the 
intervention.
Before the primary outcome endpoint at three 
months 64/568 (11%) participants died in the interven-
tion arm and 52/474 (11%) in the control arm (116 partic-
ipants in total). Between the three and six month 
follow-up 42/504 (8%) participants died in the interven-
tion arm and 34/422 (8%) in the control arm (76 partici-
pants in total). Between the six and 12 month follow-up 
55/462 (12%) participants died in the intervention arm 
and 66/388 (17%) in the control arm (121 participants in 
total). A total of 313/1042 (30%) participants died during 
the trial.
Primary outcome
The estimated sample size listed in the protocol was 
900 participants at the primary endpoint. The trial 
over-recruited to allow for an increased number of 
small clusters (total recruited n = 1042). Of the partici-
pants alive at three months, the Barthel index was 
completed by 479/504 (95%) from 113 care homes in the 
intervention arm, and 391/422 (93%) from 111 care 
homes in the control arm (870 residents in total). The 
adjusted mean difference in Barthel index score 
between groups at three months was 0.19 points higher 
in the intervention arm (95% confidence interval −0.33 
to 0.70, P = 0.48). This difference did not reach statisti-
cal significance at the 0.05 level nor did it represent a 
significant clinical impact (Table 3).23
secondary outcomes
At the two subsequent follow-up endpoints, the Bar-
thel index data showed no significant differences 
between groups (Table 4). Of the participants alive at 
six months, the Barthel index was completed by 
424/462 (92%) from 111 care homes in the intervention 
arm and 369/388 (95%) from 109 care homes in the con-
trol arm (793 residents in total). At six months the 
adjusted mean difference in Barthel index score was 
0.004 points (95% confidence interval −0.52 to 0.53, 
P = 0.99). Of the participants alive at 12 months, the 
Barthel index was completed by 355/407 (87%) from 
104 care homes in the intervention arm and 285/322 
(89%) from 100 care homes in the control arm (640 res-
idents in total). At 12 months the adjusted mean differ-
ence in Barthel index score was 0.16 (−0.40 to 0.72, 
P = 0.58). The results from the secondary analyses 
assessing mobility, mood, and health related quality of 
life also showed no statistically significant or clinically 
important differences between groups, at each fol-
low-up time point (Tables 3 and 4).
table 1 | Details of clusters and personal and baseline assessment information for 
participants. values are numbers (percentages) unless stated otherwise
Characteristics intervention group Control group
Care home type
Residential care 53/114 (46) 54/114 (47)
Nursing care 61/114 (54) 60/114 (53)
Mean (SD) cluster size 5 (3.7) 4.2 (3.0)
Personal details
Mean (SD) age (years) 83.1 (9.9) 83.6 (9.5)
Men 203/568 (36) 174/474 (37)
White 517/568 (91) 445/474 (94)
Comorbidities
Cardiovascular disease 342/530 (65) 278/446 (62)
Respiratory disease 90/484 (19) 76/415 (18)
Hepatic disease 6/471 (1) 8/406 (2)
Gastrointestinal disease 96/485 (20) 78/421 (19)
Renal disease 38/461 (8) 51/410 (12)
Urological disease 92/475 (19) 80/411 (19)
Neurological disease 371/505 (73) 296/424 (70)
Musculoskeletal disease 214/474 (45) 199/425 (47)
Dermatological problems 86/459 (19) 71/403 (18)
Fall history 203/495 (41) 200/427 (47)
stroke data (confirmed by general practice)
Confirmed stroke 329/568 (58) 317/474 (67)
Confirmed transient ischaemic attack 47/568 (8) 28/474 (6)
Suspected stroke 73/568 (13) 66/474 (14)
Missing confirmation 119/568 (21) 63/474 (13)
Left sided stroke 161/318 (51) 154/283 (54)
Right sided stroke 148/318 (46) 108/283 (38)
Bilateral stroke 9/318 (3) 21/283 (7)
assessment data
Mean (SD) Sheffield screening test* (0–20) 10.9 (7.1) 11.0 (6.9)
Language impairment (< 15) 245/424 (58) 213/374 (57)
Barthel index (0–20):
 Mean (SD) score 6.5 (5.8) 6.3 (5.7)
 Very severe (0–4) 268/562 (48) 234/467 (50)
 Severe (5–9) 129/562 (23) 104/467 (22)
 Moderate (10–14) 91/562 (16) 76/467 (16)
 Mild (15–19) 64/562 (11) 46/467 (10)
 Independent (20) 10/562 (2) 7/467 (1)
Mini-mental state examination (0–30) 13.6 (9.5) 13.2 (9.0)
Cognitive impairment (0–20) 279/398 (70) 263/362 (73)
Borderline (21–23) 40/398 (10) 42/362 (12)
Mean (SD) Rivermead mobility index (0–15) 3.1 (3.8) 2.8 (3.7)
Mean (SD) geriatric depression scale-15 (0–15) 6.8 (3.9) 6.4 (3.5)
 Mild (0–4) 157/498 (32) 131/415 (32)
 Moderate (5–9) 205/498 (41) 200/425 (48)
 Severe (10–15) 136/498 (27) 84/415 (20)
Mean (SD) EQ-5D-3L† 0.20 (0.4) 0.24 (0.4)
*Sheffield screening test for acquired language disorders.
†EuroQol group 5-dimension self report questionnaire (three levels).
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adverse events
No adverse events attributable to the intervention were 
recorded. A significantly higher fall rate per resident 
was reported in the intervention arm at three months 
(rate ratio 1.74, 95% confidence interval 1.09 to 2.77, 
P = 0.02). The mean number of falls per resident during 
the first three months in the intervention arm was 0.18 
(SD 0.52) compared with 0.11 (SD 0.40) in the control 
arm. The number of residents who had a fall resulting in 
injury or medical attention during the first three months 
was 63/482 (13%) in the intervention arm and 35/408 
(9%) in the control arm. When adjustment was made for 
care home, trial administrative centre, and type of care 
home there was a suggestion of increased odds of expe-
riencing at least one fall in the intervention arm (odds 
ratio 1.55, 95% confidence interval 0.96 to 2.53, P = 0.07).
subgroup analyses
Exploratory subgroup analyses were performed to 
assess whether response to the intervention at the pri-
mary endpoint differed according to a predefined list of 
variables, compared with a balanced control popula-
tion. Analyses considered participants’ age, type of care 
home, Barthel index severity rating, level of cognitive 
impairment, and whether the measures were completed 
by the participant or a consultee. None of the explor-
atory subgroup analyses provided evidence of a signifi-
cant difference between groups (fig 3). The effect sizes, 
based on change in Barthel index score between base-
line and three months, were also similar between 
groups (Table 5).
sensitivity analyses
A sensitivity analysis excluding small clusters with 
fewer than three residents did not alter the results. Sim-
ilarly, imputation of missing Barthel index scores using 
three methods (best case, worst care, and multiple 
imputation) did not change the conclusions. A further 
complete case analysis tested the robustness of the 
reported Barthel index analysis and gave similar 
results. The complete case analysis did not involve 
imputing zero for those with missing data due to death. 
The difference in adjusted mean Barthel index score for 
the complete case analysis between the groups at three 
months was 0.15 higher in the intervention arm (95% 
confidence interval −0.33 to 0.64, P = 0.53). To examine 
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Fig 2 | relation between baseline barthel index scores and baseline rivermead mobility 
index scores across both treatment arms (n = 1012). barthel index scores 0–20, 20 signifying 
maximum ability; rivermead mobility index scores 0–15, 15 signifying maximum ability
table 2 | three examples of treatment plans, with recommendations left for care home staff
resident and 
problem identified goals actions Outcome (including recommendations for staff)
Resident A:
 Dressing To dress top half of body 
independently
Assessment of perception 
and motor skills
Able to dress and undress top half safely and with minimal assistance but requires time and 
prompting, although he tires quickly. Encourage resident A to participate in dressing 
whenever possible
 Feeding To feed independently Issued right angled light 
weight spoon
Managed independently with the spoon but tired quickly and had difficulty finding food on 
the plate. Encourage independence with feeding within resident A’s stamina levels. 
Resident A still requires supervision and assistance. Position in wheelchair to facilitate 
independent function when eating at the table. Placement of feet on the floor may assist 
with sitting balance
 Transfer from chair Standing from a chair Supply chair raisers to 
facilitate standing from a 
chair
Ensure height of chair is correct. Resident A requires constant prompting and may require 
assistance to position feet before standing. Use hoist if unable to weight bear or to follow 
instructions to stand
Resident B:
 Mobility/transfers Standing from a chair Practice transferring from 
wheelchair to chair
Resident B was able to transfer between two chairs safely and independently. Ensure height 
of chair is correct. May require prompting to push up from the chair and may require 
assistance to position feet before standing
Walking with three 
wheeled walker
Walking practice, replace 
ferrules on walking aid
Resident B leans heavily on walking frame when mobilising, but mobilises safely and 
independently with walking frame. However, some supervision and prompting required 
because of difficulty anticipating manoeuvres required to sit in a chair safely. Continue to 
use walking frame
Resident C:
 Dressing To participate in 
dressing
Dressing assessment Encourage resident C to continue dressing independently
 Mobility To maintain mobility Assessment of walking aid Replace ferrules. Check ferrules regularly for wear
 Transfers To maintain safe and 
independent transfers
Advise on use of bed lever Encourage correct transfer technique. Prompt resident C to come to the front of the chair 
and to push up to stand from the bed and chair; encourage use of the bed lever when sitting 
up in bed and pushing up to stand
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the influence of a potential ceiling effect, we excluded 
the 52/1042 (5%) participants who had a baseline Bar-
thel index score of 18 or more. The result was unchanged 
(difference in adjusted means between the two groups 
was 0.12, −0.38 to 0.61, P = 0.64).
economic analysis
Based on cost per quality adjusted life year, we found it 
unlikely that the trialled intervention was more cost 
effective than usual treatment. We did not find a reduc-
tion in health resource use that could have outweighed 
the cost of the intervention. Therefore, although out-
comes were virtually equivalent in both arms, costs 
were higher in the intervention arm.
discussion
In this phase III cluster randomised controlled trial we 
found no evidence of benefit of a three month course of 
individualised occupational therapy, involving patient 
centred goal setting, education of staff, and appropriate 
adaptation of the environment, for care homes resi-
dents with stroke related disabilities. The intervention 
did not have an impact on participants’ level of func-
tional activity, as measured by the Barthel index at each 
endpoint. Furthermore, subgroup analyses found no 
evidence of a difference in Barthel index scores in any 
subgroup (fig 3). Removal of clusters with fewer than 
three residents, or imputation of missing data, did not 
change this result. We also found no evidence of any 
influence of the intervention on the secondary 
table 3 | Comparison of primary and secondary outcome measures at three month follow-up assessment
Outcome
intervention Control
adjusted  
mean* (se) no
adjusted 
mean* (se) no baseline iCC (95% Ci)
adjusted iCC† 
(95% Ci)
Difference in adjusted 
means (95% Ci) P value
Primary:
 Barthel index‡ 5.47 (0.20) 540 5.29 (0.21) 436 0.36 (0.29 to 0.43) 0.09 (0.05 to 0.17) 0.19 (−0.33 to 0.70) 0.48
Secondary:
 Rivermead mobility index 2.74 (0.11) 465 2.73 (0.12) 382 0.28 (0.21 to 0.36) 0.04 (0.01 to 0.15) 0.02 (−0.28 to 0.31) 0.90
 Geriatric depression scale-15 6.09 (0.21) 383 6.30 (0.22) 324 0.11 (0.06 to 0.18) 0.07 (0.03 to 0.17) −0.21 (−0.76 to 0.33) 0.44
 EQ-5D-3L§ 0.24 (0.02) 409 0.23 (0.02) 338 0.25 (0.18 to 0.33) 0.06 (0.02 to 0.17) 0.01 (−0.04 to 0.06) 0.65
ICC = model based intracluster correlation coefficient.
*Adjusted for care home as random effect, and baseline score, type of care home, and administrative centre as fixed effects.
†Adjusted for baseline score, treatment arm, type of care home, and administrative centre.
‡Participants who died before follow-up are given a Barthel score of zero.
§EuroQol group 5-dimension self report questionnaire (three levels).
table 4 | Comparison of primary and secondary outcomes at six and 12 month follow-up assessments
intervention Control
Outcome by follow-up
adjusted  
mean* (se) no
adjusted 
mean* (se) no
Difference in adjusted 
means (95% Ci)† P value†
group×time 
interaction
Primary
Barthel index‡:
 6 months 4.78 (0.20) 525 4.78 (0.22) 448 0.004 (−0.52 to 0.53) 0.99 0.35
 12 months 3.93 (0.21) 512 3.77 (0.22) 430 0.16 (−0.40 to 0.72) 0.58
secondary
Rivermead mobility index:
 6 months 2.64 (0.11) 421 2.67 (0.12) 346 −0.03 (−0.33 to 0.27) 0.84 0.23
 12 months 2.19 (0.13) 354 2.46 (0.14) 271 −0.26 (−0.62 to 0.09) 0.15
Geriatric depression scale-15:
 6 months 6.20 (0.21) 338 6.68 (0.22) 284 −0.48 (−1.04 to 0.09) 0.10 0.57
 12 months 6.22 (0.22) 297 6.40 (0.25) 219 −0.18 (−0.80 to 0.43) 0.56
EQ-5D-3L§:
 6 months 0.22 (0.02) 363 0.23 (0.02) 315 −0.01 (−0.05 to 0.04) 0.72 0.56
 12 months 0.20 (0.02) 316 0.18 (0.02) 244 0.02 (−0.03 to 0.07) 0.48
*Adjusted by care home as a random effect, and baseline score, type of care home and centre as fixed effects.
†Tukey-Kramer adjusted confidence intervals and P values.
‡Participants who died before follow-up are given a Barthel score of zero.
§EuroQol group 5-dimension self report questionnaire (three levels).
table 5 | Comparison of barthel index grouped outcome at all follow-up time points. 
values are numbers (percentages) unless stated otherwise
barthel index grouped outcome* 
by follow-up
intervention 
group Control group Odds ratio† (95% Ci) P value
3 months:
 Poor 293/540 (54) 227/436 (52) 0.96 (0.70 to 1.33) 0.81
 Moderate 164/540 (30) 150/436 (34)
 Good 83/540 (15) 59/436 (14)
6 months:
 Poor 306/526 (58) 269/449 (60) 0.95 (0.71 to 1.27) 0.74
 Moderate 161/526 (31) 122/449 (27)
 Good 59/526 (11) 58/449 (13)
12 months:
 Poor 350/513 (68) 314/432 (73) 0.84 (0.61 to 1.15) 0.27
 Moderate 121/513 (24) 77/432 (18)
 Good 42/513 (8) 41/432 (9)
*Based on change in Barthel index score from baseline (< 0 or death = poor, 0–1 = moderate, ≥ 2 = good).
†Proportional odds of improvement in outcome after intervention compared with control; adjusted by care home 
as a random effect and type of care home and centre as fixed effects.
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 measures (mood, mobility, and health related quality of 
life). A process evaluation examining the fidelity of the 
occupational therapy intervention for residents with 
stroke related disabilities living in UK care homes is pre-
sented elsewhere.31 The indications of promise observed 
during the pilot phase were not substantiated.12
A fundamental difference between this trial and the 
pilot trial was the mean Barthel index score at baseline. In 
the pilot trial, the mean baseline Barthel score in the inter-
vention arm was in the moderate range, whereas the mean 
baseline score in the intervention arm of the larger trial 
was in the severe range, with 268 out of 562 (47%) partici-
pants graded as very severe (Table 1). The observed preva-
lence of severe limitations on functional activity among 
UK care home residents with stroke related disabilities is 
one of the results that deserves attention from this trial.
No adverse events attributable to the intervention 
were reported; however, a significantly higher rate of 
falls per resident was reported in the intervention arm 
than in the control arm (482 v 408) during the first three 
months. The mean number of falls per resident during 
the first three months in the intervention arm was 0.18 
(SD 0.52). According to recently published figures,32–34 
the average fall risk for older adults living in long term 
care institutions varies from 1.49–2.5 per annum. This 
suggests that the quarterly fall rate of 0.18 observed in 
the intervention arm was within the normal range.
strengths and weaknesses of this study
This is the largest cluster randomised controlled trial 
of  occupational therapy conducted in care homes. 
 Recruitment levels were high and a large number of 
care homes indicated interest. We found that many care 
home managers were receptive to research activity 
seeking to benefit residents. The large geographical dis-
tribution of different types of care home, combined with 
the involvement of a high number of qualified thera-
pists and a protocol that did not exclude resident survi-
vors of stroke with cognitive and communication 
impairments, increase the potential for generalisability 
of the observed results to all care homes within the 
United Kingdom. Tolerance of the intervention was 
good, resulting in no adverse events and high comple-
tion rates for all assessments at each endpoint. Partici-
pant baseline characteristics were representative of the 
UK care home population for age, sex balance, and lev-
els of support needed.35 The occupational therapy 
offered to participants was similar to that shown to ben-
efit survivors of stroke living in their own homes, and 
similar to a standard NHS intervention.7 The sample 
size calculation was based on an intracluster correla-
tion coefficient of 0.37 from a previous pilot study.28 The 
unadjusted intracluster correlation coefficient for Bar-
thel index scores in this trial was 0.36 at baseline; how-
ever, for the change in scores from baseline to three 
months, allowing for the effect of treatment, trial 
administrative centre, and type of care home, it 
decreased to 0.09 (Table 3).
Several potential limitations are acknowledged. 
Firstly, the percentage of care home residents affected 
by stroke was less than expected, which resulted in a 
larger number of small clusters than was originally 
anticipated. It has been noted elsewhere that the inci-
dence of stroke in UK care homes decreased between 
2009 and 2012, from 20% to 16%.36 The 16% incidence 
of stroke in the current study concurred with this find-
ing. Despite multiple attempts at contacting general 
practices, confirmation of participants’ stroke was 
missing in 17% of cases across both treatment arms, 
indicating a lack of integration between care homes 
and local health services.37 The mean age of partici-
pants (82.9 years) was also lower than expected. There 
were six reported cases of treatment allocation being 
revealed to the assessors by residents or staff. The 
potential influence of these cases of unblinding on the 
overall result is regarded to be minimal.
The high proportion of participants with cognitive 
impairment and depression scores indicative of moder-
ate to severe depression may have potentially limited 
engagement in therapy. Similarly, most participants 
(> 70%) were graded as severe or very severe on the Bar-
thel index at baseline, which may also have limited the 
participants’ capacity to engage in therapy (Table 1). It 
is possible the occupational therapy intervention was 
more suited to participants graded as less severe on the 
Barthel index scale at baseline (Fig 3). However, the 
current data did not support this assertion. The severity 
rating of Barthel index score at baseline had no signifi-
cant mediating influence on participants’ response to 
the intervention at three months according to the 
exploratory subgroup analysis. Despite these potential 
limitations, the estimates of the potential effect of the 
Questionnaire completer
  Consultee
  Resident
Baseline Barthel index
  Very severe (0-4)
  Severe (5-9)
  Moderate (10-14)
  Mild-independent (15-20)
Cognitive impairment (MMSE)
  Very cognitively impaired (0-9)
  Rest (10-30)
Type of care home
  Residential
  Nursing
Age
  <75
  75-84
  85-94
  ≥95
All participants 
-0.17 (-0.91 to 0.57)
0.43 (-0.20 to 1.06)
0.06 (-0.63 to 0.75)
-0.28 (-1.21 to 0.65)
0.27 (-0.81 to 1.35)
1.23 (-0.06 to 2.52)
-0.02 (-0.92 to 0.88)
0.84 (0.06 to 1.62)
0.40 (-0.41 to 1.22)
0.05 (-0.61 to 0.70)
-0.42 (-1.53 to 0.69)
-0.02 (-0.79 to 0.75)
0.46 (-0.25 to 1.17)
0.07 (-1.53 to 1.66)
0.19 (-0.33 to 0.70)
-2 -1 0 1 2 3
Favours
treatment
Favours
control
Dierence in
adjusted means
(95% CI)*
Dierence in
adjusted means
(95% CI)*
425
551
479
220
159
118
258
330
350
626
154
334
417
69
976
No
0.19
0.29
0.13
0.51
0.53
P value
Fig 3 | exploratory subgroup analysis: comparison of barthel index at three months. *type of 
care home means were adjusted for care home as a random effect and baseline barthel index 
score and trial administrative centre as fixed effects. all other subgroup means were adjusted 
for care home as a random effect and baseline barthel index score, trial administrative centre, 
and type of care home as fixed effects. MMse = mini-mental state examination
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intervention are regarded as precise. The evidence 
 presented here does not support the use of a routine 
occupational therapy intervention to maintain levels of 
functional activity for older care home residents with 
stroke related disabilities. However, it may be the case 
that individual referrals within a care home setting may 
be of benefit to residents with lower levels of impairment.
Findings in context
These findings concur with the results of other recently 
published large randomised control trials conducted 
in care homes.38 39 Furthermore, a recent meta-analy-
sis that focused on the influence of physical rehabilita-
tion on the performance of personal activities of daily 
living for residents in long term institutional care 
reported the potential for relatively small effect sizes 
overall.40 In light of these neutral results, it prompts 
the question “Do we expect too much from this pre-
dominantly frail population, with a high incidence of 
cognitive impairment, depression, and dementia, to 
respond to individual activity based interactive inter-
ventions (fig 2)?” A reasonable conclusion from this 
trial is that most participants were incapable of engag-
ing in therapy. A recent review by the Care Quality 
Commission highlighted the need for residents in care 
homes to exert choice and control over their health-
care, whenever possible, and to promote care activi-
ties that are, most importantly, safe and that respect 
residents’ dignity.41 These are values that the interven-
tion was attempting to promote, but the findings sug-
gest that this inactive population, with low autonomy, 
may need alternative approaches. Furthermore, the 
concept and application of patient centred goal setting 
may require further scrutiny in the context of this clin-
ically complex population.
A changing role of care homes is acknowledged in 
recent reports from the Centre for Policy and Aging.35 36 
The emphasis now is more on providing care for resi-
dents with high support needs for a short period 
towards the end of life. Attention must be given to how 
the care home environment can be suitably modified to 
tackle these needs. Observations from therapists 
administering the intervention were that the level of 
adaptive equipment in use in the participating care 
homes was relatively low and highly variable. As a 
result of the number of patients after stroke transferring 
directly from hospital to a care home environment,3 as 
opposed to returning home, it is necessary for rehabili-
tation and social care services to achieve equivalent 
standards, especially for those patients living with high 
support needs.9 42 It is predicted that by 2031, 22% of the 
population will be more than 65 years old, and the over 
85s age bracket is the fastest growing sector.43 44 The 
prevalence of stroke and dementia in this population 
suggests a huge demand for long term care facilities 
both now and in the future.45 Future research needs to 
identify applicable criteria to promote an enabling envi-
ronment within care homes.
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